Multicellular Tumour Spheroids Exposure to Pulsed Electric Field: A Combined Experimental and Mathematical Modelling Study Highlighting Temporal Dynamics of DAMP Release and Accelerated Regrowth at Intermediate Field Intensities

This study combines in vitro experiments and hybrid computational modeling to reveal how pulsed electric field intensity governs the temporal dynamics of damage-associated molecular pattern release and the dual fate of quiescent cells, ultimately driving either tumor suppression or accelerated regrowth in multicellular tumor spheroids.

The Gist

Here is an explanation of the research paper, translated into everyday language with some creative analogies.

The Big Picture: A High-Voltage Game of "Hot Potato" with Cancer

Imagine you have a dense, tangled ball of yarn (the tumor) that you need to untangle or destroy. Doctors have a tool called Electroporation (specifically Irreversible Electroporation or IRE). Think of this tool as a giant, precise lightning bolt. When they zap the tumor with electricity, it punches tiny holes in the cancer cells' walls, causing them to burst or die.

The goal is to kill the tumor completely. But here's the problem: sometimes, the lightning bolt doesn't hit every single thread of yarn equally. Some parts get a massive shock, some get a weak one, and some get none at all.

This study asked two big questions:

1. What happens to the tumor after the zap? Does it die, or does it grow back?
2. Does the zap send out an "SOS" signal to the body's immune system? (When cells die, they release chemical flags called DAMPs that tell the immune system, "Hey, something bad happened here, come attack!")

To answer this, the researchers didn't just use flat cells on a slide (which is like studying a single brick). They used 3D tumor spheroids—tiny, round balls of cancer cells that look and act more like a real tumor in a human body. They zapped these balls with different strengths of electricity and used a computer model to predict what would happen.

---

The Three Zones of the Tumor Ball

Before the zap, these little tumor balls have three distinct neighborhoods, just like a city:

1. The Busy Downtown (Proliferative Cells): The outer edge where cells are eating, drinking, and dividing rapidly.
2. The Quiet Suburbs (Quiescent Cells): As you go deeper, there isn't enough food or oxygen. These cells stop dividing and go into "sleep mode" to survive. They aren't dead, just resting.
3. The Dead Center (Necrotic Core): In the very middle, it's so crowded and starved that cells have already died and are rotting.

The Experiment: Zapping with Different Voltages

The researchers zapped these tumor balls with three different levels of electricity: Low, Medium, and High.

1. The Low Voltage (500 V/cm)

• The Result: It was like a gentle breeze. The tumor didn't really notice. It kept growing just like an untreated tumor.
• The Lesson: If the electric field is too weak, it's useless.

2. The High Voltage (2500 V/cm)

• The Result: This was the "nuclear option." The electric shock was so strong it killed almost everything immediately. The tumor stopped growing and stayed dead.
• The Lesson: This is the ideal outcome for a perfect treatment, but in real life, it's hard to hit every single cell with this much power because of the shape of the body and the tumor.

3. The Medium Voltage (1500 V/cm) – The Surprise Twist!

• The Result: This is where it got weird. The zap killed some cells, but not all. The tumor shrank a little, but then... it started growing back faster than before!
• The Analogy: Imagine you have a crowded concert hall. If you kick out 20% of the audience (the cells that died), the remaining people suddenly have more room to dance and move around. They aren't just happy; they are super happy and start dancing twice as fast.
• The Mechanism: The electric shock killed some of the "sleeping" (quiescent) cells in the middle. This freed up space and resources (food/oxygen) for the surviving "busy" cells on the outside. These survivors woke up, realized they had a buffet, and started reproducing like crazy.
• The Danger: This is a warning for doctors. If you don't zap hard enough to kill everything, you might accidentally give the survivors a "growth spurt," making the tumor come back stronger.

The "SOS" Signals (DAMPs)

When cells die, they release chemical flags called DAMPs (specifically ATP and HMGB1). Think of these as flares shot into the sky to tell the immune system (the police) to come and clean up the mess.

• High Voltage: The cells died so fast and violently that they shot off flares immediately. The immune system gets the signal right away.
• Medium Voltage: The cells died more slowly. The flares were shot off later.
• The Takeaway: The timing of the "SOS" signal depends on how hard you zap. If you want the immune system to help you, you need to know exactly when to send it in.

The Computer "Digital Twin"

The researchers built a computer model (a "Digital Twin") to simulate these experiments.

• They programmed the computer to act like the tumor balls: cells eating, sleeping, and dying.
• They fed the computer the real experimental data.
• The Result: The computer predicted exactly what the real labs saw! It confirmed that the "Medium Voltage" danger zone exists and explained why it happens (the "freed space" theory).

Why This Matters for Patients

This study is a wake-up call for cancer treatments using electricity:

1. Don't be half-hearted: If you don't zap hard enough, you might not kill the tumor, and you might accidentally make it grow back faster.
2. Timing is everything: The way the tumor signals the immune system changes based on how much electricity is used. Doctors might need to time their immunotherapy drugs (like checkpoint inhibitors) to arrive exactly when the tumor is shouting its "SOS" signal.
3. The "Sleeping" Cells are Key: The cells that were just "sleeping" (quiescent) are the ones that wake up and cause the regrowth if the treatment isn't strong enough.

In a Nutshell

The researchers found that killing cancer with electricity is a delicate balance. Too little power, and the tumor ignores you. Too much, and you kill it all (which is good, but hard to achieve perfectly). But if you hit that "medium" sweet spot, you might accidentally wake up the survivors and make them grow back faster.

Their computer model is now a tool that doctors can use to figure out the perfect "zap" settings to kill the tumor without accidentally feeding the survivors, and to time the immune system's arrival perfectly to finish the job.

Technical Summary

Here is a detailed technical summary of the paper "Multicellular Tumour Spheroids Exposure to Pulsed Electric Field: A Combined Experimental and Mathematical Modelling Study."

1. Problem Statement

Irreversible Electroporation (IRE) is a non-thermal ablation technique used to treat solid tumors near vital structures. While effective, clinical outcomes are often compromised by tumor relapse. This recurrence is frequently attributed to:

• Heterogeneous electric field distribution: Anatomical limitations and tissue heterogeneity can lead to incomplete coverage, leaving residual viable cells.
• Incomplete understanding of post-treatment dynamics: Specifically, the spatio-temporal mechanisms of Immunogenic Cell Death (ICD) and the release of Damage-Associated Molecular Patterns (DAMPs) in 3D tumor structures are not fully elucidated.
• The "Intermediate Intensity" Paradox: There is a lack of data on how sub-lethal or intermediate electric field intensities affect tumor regrowth and immune signaling compared to lethal or non-lethal doses.

The study aims to address two key questions: (1) What dynamics drive tumor regrowth after partial ablation? and (2) How do ICD and DAMP release unfold in space and time within 3D cellular structures that better mimic in vivo conditions than 2D cultures?

2. Methodology

The study employs a hybrid approach combining in vitro experiments with a hybrid Individual-Based Model (IBM) coupled with continuous partial differential equations (PDEs).

A. Experimental Component

• Model System: Murine hepatocarcinoma cell line (Hepa 1-6) grown as 3D multicellular spheroids (approx. 300 µm diameter) to mimic the avascular stage of solid tumors with internal gradients of nutrients, oxygen, and cell states (proliferative, quiescent, necrotic).
• Treatment: Spheroids were exposed to 80 unipolar pulses (100 µs duration, 1000 Hz) at varying electric field intensities: 0, 500, 1000, 1500, 2000, and 2500 V/cm.
• Measurements:
  • Viability & Growth: Tracked via GFP fluorescence and Propidium Iodide (PI) staining over 4 days.
  • Apoptosis: Measured via Caspase 3/7 activation kinetics.
  • DAMP Release: Quantified extracellular ATP (10 min and 24h post-treatment) and HMGB1 (3h and 6h post-treatment) via luminescence and immunoblotting.
  • Controls: pH measurements confirmed that cell death was not due to electrolysis.

B. Mathematical Modeling Component

• Model Type: A Hybrid Individual-Based Model (IBM) on a 2D Cartesian grid.
  • Agents: Individual cells are tracked as agents with states: Proliferative, Quiescent, and Necrotic.
  • Environment: Nutrient concentration is modeled via a PDE (diffusion-consumption equation).
  • Mechanisms:
    • Proliferation: Driven by local nutrient levels; cells stop dividing and become quiescent when packing density is high or nutrients are low.
    • Necrosis: Triggered by hypoxia (low nutrients).
    • Electroporation Effect: Modeled as an immediate reduction in cell viability proportional to ATP release. The model assumes cell death probability is inversely proportional to pulse intensity (higher intensity = faster death).
    • DAMP Dynamics:
      • ATP: Modeled as a quadratic function of electric field intensity ($S \propto E^2$).
      • HMGB1: Released by dying cells; the total amount is proportional to the cumulative number of dead cells over time.
• Calibration & Validation: The model was calibrated using data from 0, 500, 1500, and 2500 V/cm conditions. It was then validated against independent experimental data from 1000 and 2000 V/cm conditions.

3. Key Contributions

1. Discovery of Accelerated Regrowth at Intermediate Intensities: The study identifies a counter-intuitive phenomenon where intermediate electric field intensities (e.g., 1500 V/cm) cause partial ablation but subsequently accelerate tumor regrowth compared to untreated controls.
2. Mechanistic Insight via Hybrid Modeling: The authors developed a validated digital twin that explains why regrowth accelerates: the death of quiescent and proliferative cells at intermediate intensities frees up space and resources, allowing surviving proliferative cells to resume the cell cycle more rapidly.
3. Spatio-Temporal DAMP Kinetics: The study maps the delayed release of HMGB1 at intermediate intensities compared to the rapid release at high intensities, linking this delay to the kinetics of apoptosis and the specific cell states (quiescent vs. proliferative) affected.
4. Integration of 3D Biology and Computation: By using spheroids instead of monolayers, the study captures the critical role of cell density gradients (proliferative rim vs. quiescent/necrotic core) in determining treatment outcomes.

4. Key Results

Experimental Findings

• Low Intensity (500 V/cm): No significant impact on viability, growth, or DAMP release compared to controls.
• Intermediate Intensity (1500 V/cm):
  • Induced immediate loss of viability followed by significant regrowth (growth speed exceeded pre-treatment rates).
  • Delayed DAMP Release: HMGB1 was detected at 6 hours (but not 3 hours), and Caspase 3/7 activation peaked later (6 hours) compared to high intensity.
  • Loss of Necrotic Core: Post-treatment spheroids lacked the central necrotic core seen in controls, indicating uniform regrowth across the structure.
• High Intensity (2500 V/cm):
  • Caused massive, persistent loss of viability with growth inhibition.
  • Rapid DAMP Release: HMGB1 and Caspase 3/7 activation peaked rapidly (3 hours).
  • Complete ablation of the majority of spheroids.

Modeling Findings

• Validation: The hybrid IBM successfully reproduced the experimental growth curves, cell death kinetics, and DAMP release profiles across all tested intensities.
• The "Quiescent Cell" Mechanism: The model revealed that at 1500 V/cm, the death of quiescent cells (which normally occupy the core) removes spatial constraints. This allows the remaining proliferative cells at the periphery to expand rapidly, explaining the accelerated regrowth.
• DAMP Correlation: The quadratic relationship between electric field intensity and ATP release was confirmed. The model successfully predicted that HMGB1 release timing is strictly dependent on the speed of cell death, which is a function of field intensity.

5. Significance and Implications

• Clinical Warning: The findings suggest that suboptimal IRE treatment (due to poor electrode placement or tissue heterogeneity resulting in intermediate field intensities) may inadvertently stimulate tumor recurrence by creating a resource-rich environment for surviving cells.
• Therapeutic Scheduling: The study highlights the importance of timing in immunotherapy. Since DAMP release (specifically HMGB1) is delayed at intermediate intensities, the window for immune system activation differs based on pulse intensity. Optimizing the combination of IRE and immunotherapy requires matching the administration of immune checkpoint inhibitors or cytokines to these specific kinetic windows.
• Modeling Utility: The proposed hybrid IBM serves as a cost-effective "digital twin" to predict tumor responses to varying pulse parameters, potentially guiding the design of future clinical trials and personalized treatment protocols to avoid the "danger zone" of intermediate intensities.
• Future Directions: The authors propose extending the model to include immune cells and Reactive Oxygen Species (ROS) to fully capture the in vivo immune response and oxidative stress mechanisms.

In conclusion, this study provides a critical mechanistic understanding of how electric field intensity dictates the balance between tumor ablation, immune signaling, and regrowth, emphasizing that intermediate intensities pose a unique risk of accelerating tumor recurrence if not managed with precise dosing or combined with immunotherapies.